These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38757155)

  • 1. Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT in diagnosing portal vein tumor thrombosis.
    Mititelu R; Mitoi A; Mazilu C; Jinga M; Radu FI; Bucurica A; Mititelu T; Bucurica S
    Nucl Med Commun; 2024 Aug; 45(8):651-657. PubMed ID: 38757155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of
    Wu B; Zhang Y; Tan H; Shi H
    Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT.
    Agarwal KK; Shah D; Shah N; Mayank M
    Clin Nucl Med; 2017 Nov; 42(11):e472-e474. PubMed ID: 28922192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
    Lee JW; Hwang SH; Kim DY; Han KH; Yun M
    Clin Nucl Med; 2017 Jan; 42(1):e35-e40. PubMed ID: 27775940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
    Sun L; Guan YS; Pan WM; Chen GB; Luo ZM; Wei JH; Wu H
    World J Gastroenterol; 2008 Feb; 14(8):1212-7. PubMed ID: 18300346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
    Sun L; Wu H; Pan WM; Guan YS
    World J Gastroenterol; 2007 Sep; 13(33):4529-32. PubMed ID: 17724816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein and
    Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma.
    Cerrito L; Ainora ME; Di Francesco S; Galasso L; Gasbarrini A; Zocco MA
    Tomography; 2023 Oct; 9(5):1976-1986. PubMed ID: 37888746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
    Tarantino L; Ambrosino P; Di Minno MN
    World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
    Zhou X; Hu Y; Sun H; Chen R; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3107-3115. PubMed ID: 37147479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal venous tumor growth-type of hepatocellular carcinoma without liver parenchyma tumor nodules: a case report.
    Saito M; Seo Y; Yano Y; Uehara K; Hara S; Momose K; Hirano H; Yokozaki H; Yoshida M; Azuma T
    Ann Hepatol; 2013; 12(6):969-73. PubMed ID: 24114829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus.
    Hanajiri K; Mitsui H; Maruyama T; Kondo Y; Shiina S; Omata M; Nakagawa K
    J Gastroenterol; 2005 Oct; 40(10):1005-6. PubMed ID: 16261443
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT.
    Nguyen XC; Nguyen DS; Ngo VT; Maurea S
    Asia Ocean J Nucl Med Biol; 2015; 3(1):10-7. PubMed ID: 27408876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of regional functional liver volume assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus.
    Araki K; Harimoto N; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Tsushima Y; Shirabe K
    Surg Today; 2020 Nov; 50(11):1496-1506. PubMed ID: 32613270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
    Piscaglia F; Gianstefani A; Ravaioli M; Golfieri R; Cappelli A; Giampalma E; Sagrini E; Imbriaco G; Pinna AD; Bolondi L;
    Liver Transpl; 2010 May; 16(5):658-67. PubMed ID: 20440775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
    Yamashige D; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
    Oncology; 2021; 99(3):169-176. PubMed ID: 33207358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.